Referencias
-
Estudio médico de AplusA, realizado con 95 pacientes que usaron Narval CC (Equinoxe en Francia) en 2011.
-
Peepard, T. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med, 342 (2000), pg. 1378-1384.
3: Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005. 365: 1046-53.
4: Meslier N, Racineux JL. Ronflement et syndrome de haute résistance. Rev Mal Respir 2004. 21: 2S35-2S42.
5: Young, T et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993. 328 (17): 1230-5.
6: Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnea: a long-term follow-up. Eur Respir J. Septiembre de 2006. 28 (3): 596-602.
7: Peepard T. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342 (2000), pg. 1378-1384.
8: Ellen et al. Systematic review of motor vehicle crash risk in persons with sleep apnea. J Clin Sleep Med. 15 de abril de 2006. 2 (2): 193-200.
9: Vecchierini MF & al. A custom-made mandibular repositioning device for obstructive sleep apnoea-hypopnoea syndrome: the ORCADES study. Sleep Med. Marzo de 2016; 19:131-40. DOI: 10,1016.